Teva Pharmaceuticals To Expand in Canada With $6M Grant
05/28/2010
"Teva's high potent product manufacturing facility expansion in Stouffville, Ontario will enable use to secure Canadian and export mandates for high-quality, value-priced generic medicines," said Barry Fishman, president and CEO of Teva Canada Limited. "This partnership with the Ontario government to construct an advanced manufacturing facility will increase Teva Canada's capabilities and capacity and allow us to retain and grow high-value jobs in Ontario."
The same day the expansion was announced, Ontario Premier Dalton McGuinty met with scientists from Israel's Weizman Institute of Science to discuss new partnership opportunities. Among the Institute's research are ways to eliminate famine.
"Teva Pharmaceuticals is a perfect example of the kind of partner we're looking for in Israel," McGuinty said.
Project Announcements
Eos Energy Enterprises Expands Allegheny County, Pennsylvania, Operations
11/01/2025
Ahold Delhaize USA Plans Burlington, North Carolina, Distribution Operations
11/01/2025
Ulbrich Specialty Wire Products Expands Westminster, South Carolina, Production Operation
11/01/2025
Alcoa Expands Massena, New York, Operations
11/01/2025
SmartWiz Expands Birmingham, Alabama, Headquarters Operations
11/01/2025
Dutch-Based Maars North America Plans Mount Pleasant, South Carolina, Production Operations
11/01/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025